WFSBP Programme 2015

77 / 112

75
WFSBP 2015
Thursday, 18 June 2015 | Scientific Programme
S-48-003
The syndrome of schizophrenia: Progress towards potential
biomarkers
Elizabeth Scarr, Australia
S-48-004
Autophagy as future treatment target for schizophrenia:
Lessons from activity-dependent neuroprotective protein
Illana Gozes, Israel
T38: Psychopathology
S-49 Symposium
08:30–10:00 MC 2 Room
Psychobiology of men‘s mental health
Chair: Leo Sher, USA
Co-Chair: Zoltan Rihmer, Hungary
S-49-001
The WFSBP Men‘s Mental Health Task Force: Rationale for
a neuroendocrine-focused approach to men‘s mental health
Timothy Rice, USA
S-49-002
Depression in men: Clinical and phenomenological aspects
Wolfgang Rutz, Sweden
S-49-003
Suicide in men: Hormonal and neurobiological correlates
Zoltan Rihmer, Hungary
S-49-004
Testosterone, violence and homicide
Leo Sher, USA
T32: Pharmacology
S-50 Symposium
08:30–10:00 Kokkali Room
The importance of pharmacovigilance in psychiatric
inpatient populations
Chair: Stefan Bleich, Germany
Co-Chair: Anastasios Konstantinidis, Austria
S-50-001
Systematic pharmacovigilance in psychiatry – Is it necessary?
Sermin Toto, Germany
S-50-002
Suicidality during antidepressant treatment in a psychiatric
inpatient population
Susanne Stübner, Germany
S-50-003
Restless legs syndrome induced by psychotropic treatment
Konstantinos Papageorgiou, Austria
A. Konstantinidis, S. Toto, R. Grohmann, S. Kasper
S-50-004
Polypharmacy in psychiatry – a risk factor for adverse
events?
Anastasios Konstantinidis, Austria
T46: Suicide: Basic/ Clinical
S-51 Symposium
11:00–12:30 Mitropoulos Hall
Molecular determinants of suicide
Chair: Ghanshyam Pandey, USA
Co-Chair: John Mann, USA
S-51-001
Imaging studies of suicidal behavior neural circuitry
John Mann, USA
S-51-002
Neuroinflammatory markers in suicide brain: Focus on
cytokine receptors and toll-like receptors
Ghanshyam Pandey, USA
S-51-003
Epigenomic basis for astrocyte abnormalities in suicidal
behavior
Gustavo Turecki, Canada
S-51-004
Role of microRNAs in the etiology and treatment of depres-
sive disorder and suicide
Yogesh Dwivedi, USA
T6: Bipolar Disorders: Basic/ Clinical
S-06 Symposium
11:00–12:30 Skalkotas Hall
Major controversies for the treatment of bipolar disorders
Chair: Gustavo Vazquez, Argentina
Co-Chair: Eduard Vieta, Spain
S-06-001
Novel treatments for bipolar disorders
Eduard Vieta, Spain
S-06-002
Optimal duration of atypical antipsychotic therapy for
maintenance treatment
Lakshmi Yatham, Canada
S-06-003
Neuroprotective potential of mood stabilizers
Michael Berk, Australia
S-06-004
Use of antidepressants in bipolar disorders
Gustavo Vazquez, Argentina
L. Tondo, A. Forte, v. Selle, R. Baldessarini